valproic acid and dinoprostone

valproic acid has been researched along with dinoprostone in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19901 (7.69)18.7374
1990's1 (7.69)18.2507
2000's3 (23.08)29.6817
2010's7 (53.85)24.3611
2020's1 (7.69)2.80

Authors

AuthorsStudies
Andrews, PR; Craik, DJ; Martin, JL1
Endou, H; Hosoyamada, M; Kanai, Y; Sekine, T; Watanabe, N1
Endou, H; Kobayashi, Y; Ohshiro, N; Sasaki, T; Sekine, T; Shibusawa, A; Tokuyama, S; Yamamoto, T1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Filipek, B; Gunia-Krzyżak, A; Marona, H; Nitek, W; Pańczyk, K; Pękala, E; Rapacz, A; Słoczyńska, K; Waszkielewicz, AM; Żelaszczyk, D; Żesławska, E1
Bosetti, F; Rapoport, SI; Rosenberger, TA; Weerasinghe, GR1
Basselin, M; Bell, JM; Chang, L; Chen, M; Rapoport, SI1
Berna, M; Del Soldato, P; Giaccone, G; Jensen, RT; Moody, TW; Ridnour, LA; Roberts, DD; Santana-Flores, W; Sparatore, A; Switzer, C; Thill, M; Wink, DA; Yeh, GC1
Basselin, M; Chang, L; Chen, M; Cheon, Y; Ramadan, E; Rapoport, SI; Taha, AY1
Han, X; Liu, W; Liu, Z; Zhao, H; Zhao, M; Zheng, Q1
Ratajczak, MZ; Suszynska, M1
Baranes, S; Chapman, S; David, T; Dekel Jaoui, H; Efrati, R; Egoz, I; Gez, R; Gore, A; Grauer, E; Lazar, S; Neufeld-Cohen, A; Yampolsky, M1

Reviews

1 review(s) available for valproic acid and dinoprostone

ArticleYear
Emerging Strategies to Enhance Homing and Engraftment of Hematopoietic Stem Cells.
    Stem cell reviews and reports, 2016, Volume: 12, Issue:1

    Topics: Adenosine Triphosphate; Bone Marrow; Ceramides; Chemokine CXCL12; Chemotactic Factors; Chemotaxis; Dinoprostone; Graft Survival; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Lysophospholipids; Membrane Microdomains; Receptors, CXCR4; Sphingosine; Stem Cell Niche; Uridine Triphosphate; Valproic Acid

2016

Other Studies

12 other study(ies) available for valproic acid and dinoprostone

ArticleYear
Functional group contributions to drug-receptor interactions.
    Journal of medicinal chemistry, 1984, Volume: 27, Issue:12

    Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship

1984
Expression cloning and characterization of a novel multispecific organic anion transporter.
    The Journal of biological chemistry, 1997, Jul-25, Volume: 272, Issue:30

    Topics: Amino Acid Sequence; Animals; Anion Transport Proteins; Carrier Proteins; Cloning, Molecular; Dicarboxylic Acid Transporters; Gene Expression; Glycosylation; In Situ Hybridization; Kidney; Kinetics; Membrane Proteins; Molecular Sequence Data; Organic Anion Transporters, Sodium-Dependent; p-Aminohippuric Acid; Rats; RNA, Messenger; Symporters; Xenopus laevis

1997
Isolation, characterization and differential gene expression of multispecific organic anion transporter 2 in mice.
    Molecular pharmacology, 2002, Volume: 62, Issue:1

    Topics: Amino Acid Sequence; Animals; Chromosome Mapping; Cloning, Molecular; Gene Expression Regulation; Mice; Molecular Sequence Data; Organic Anion Transporters, Sodium-Independent; RNA, Messenger; Sequence Homology, Amino Acid; Tissue Distribution

2002
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
Structure-anticonvulsant activity studies in the group of (E)-N-cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CH
    Bioorganic & medicinal chemistry, 2017, 01-15, Volume: 25, Issue:2

    Topics: Amino Alcohols; Animals; Anticonvulsants; Crystallography, X-Ray; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Mice; Models, Molecular; Molecular Structure; Rats; Seizures; Structure-Activity Relationship

2017
Valproic acid down-regulates the conversion of arachidonic acid to eicosanoids via cyclooxygenase-1 and -2 in rat brain.
    Journal of neurochemistry, 2003, Volume: 85, Issue:3

    Topics: Animals; Arachidonate 5-Lipoxygenase; Arachidonic Acid; Brain Chemistry; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprostone; Down-Regulation; Drug Administration Schedule; Eicosanoids; Enzyme Activation; Isoenzymes; Leukotriene B4; Male; Membrane Proteins; Phospholipases A; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred F344; RNA, Messenger; Thromboxane B2; Valproic Acid

2003
Chronic administration of valproic acid reduces brain NMDA signaling via arachidonic acid in unanesthetized rats.
    Neurochemical research, 2008, Volume: 33, Issue:11

    Topics: Animals; Arachidonic Acid; Autoradiography; Behavior, Animal; Brain; Dinoprostone; Male; N-Methylaspartate; Rats; Rats, Inbred F344; Signal Transduction; Thromboxane B2; Valproic Acid

2008
Dithiolethione modified valproate and diclofenac increase E-cadherin expression and decrease proliferation of non-small cell lung cancer cells.
    Lung cancer (Amsterdam, Netherlands), 2010, Volume: 68, Issue:2

    Topics: Anethole Trithione; Animals; Cadherins; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase Inhibitors; Diclofenac; Dinoprostone; Gene Expression Regulation, Neoplastic; Humans; Isoxazoles; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Pyrazoles; Sulfones; Valproic Acid

2010
Chronic valproate treatment blocks D2-like receptor-mediated brain signaling via arachidonic acid in rats.
    Neuropharmacology, 2011, Volume: 61, Issue:8

    Topics: Analysis of Variance; Animals; Antimanic Agents; Arachidonic Acid; Autoradiography; Brain; Carbon Radioisotopes; Dinoprostone; Dopamine Agonists; Dopamine Antagonists; Male; Rats; Rats, Inbred F344; Receptors, Dopamine D2; Signal Transduction; Thromboxane B2; Valproic Acid

2011
Valproic acid protects septic mice from renal injury by reducing the inflammatory response.
    The Journal of surgical research, 2014, Volume: 192, Issue:1

    Topics: Acute Kidney Injury; Animals; Cecum; Cyclooxygenase 2; Dinoprostone; Disease Models, Animal; Histone Deacetylase Inhibitors; Mice, Inbred C57BL; Nitric Oxide; Oxidative Stress; Random Allocation; Sepsis; Valproic Acid; Wounds, Penetrating

2014
Neuroprotection by delayed triple therapy following sarin nerve agent insult in the rat.
    Toxicology and applied pharmacology, 2021, 05-15, Volume: 419

    Topics: Animals; Anticonvulsants; Behavior, Animal; Brain; Carrier Proteins; Dinoprostone; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Injections, Intramuscular; Injections, Intraperitoneal; Ketamine; Male; Midazolam; Open Field Test; Rats, Sprague-Dawley; Receptors, GABA-A; Recognition, Psychology; Sarin; Status Epilepticus; Time Factors; Valproic Acid

2021